Medtronic-Covidien deal receives antitrust clearances in China and Korea
MLex Summary: Medical device company Medtronic and Covidien said Thursday that the Chinese Ministry of Commerce and the South Korean Fair Trade Commission have cleared their planned $42.9 billion merger. The transaction is expected to close early...To view the full article, register now.
Already a subscriber? Click here to view full article